Submitted for Publication: November 11, 2014; final revision received February 20, 2015; accepted March 1, 2015.
Published Online: April 30, 2015. doi:10.1001/jamaophthalmol.2015.0893.
Study concept and design: All authors.
Acquisition, analysis, or interpretation of data: Aptel, Tamisier, Chiquet.
Drafting of the manuscript: Aptel, Khayi, Romanet, Chiquet.
Critical revision of the manuscript for important intellectual content: Aptel,Pépin, Tamisier, Levy, Romanet, Chiquet.
Statistical analysis: Aptel, Khayi, Romanet, Chiquet.
Obtained funding: Aptel, Levy, Chiquet.
Administrative, technical, or material support: Aptel, Tamisier, Romanet, Chiquet.
Study supervision: Aptel, Pépin, Levy, Chiquet.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Tamisier reported receiving an unrestricted grant for IH exposure research from Resmend Foundation. Dr Tamisier has also received a fee for consulting from Jazz Pharmaceutical. No other disclosures were reported.
Funding/Support: This study was supported by grant ETO-578 from the Fondation de l’Avenir.
Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Additional Contributions: N. Arnol, MSc, INSERM U1042, Hypoxia and Physiopathology Laboratory, Joseph Fourier University, Grenoble, France, performed the statistical analysis, and Alison Foote, PhD, Clinical Research Center, Grenoble University Hospital, translated the manuscript. No financial compensation was provided.